Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique

Journal of Microencapsulation

Volumn 28, Issue 1, 2011, Pages 46-54

  Karal Yilmaz, Okan ^a   Serhatli, Mge ^a   Baysal, Kemal ^a   Baysal, Bahattin M ^b  

^a MATERIALS INSTITUTE   (Turkey)

^b BOGAZICI UNIVERSITY   (Turkey)

Author keywords

Biodegradable polymers; Controlled release; Encapsulation; In vitro release; Microspheres; Poly(lactic glycolic) acid

Indexed keywords

DICHLOROMETHANE; MAGNESIUM DERIVATIVE; MICROSPHERE; POLYGLACTIN; RECOMBINANT VASCULOTROPIN; WATER OIL CREAM; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; RECOMBINANT PROTEIN; SOLVENT; VASCULOTROPIN A;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; ENDOTHELIUM CELL; EVAPORATION; HUMAN; HUMAN CELL; MICROEMULSION; PARTICLE SIZE; SOLVENT EVAPORATION; STEADY STATE; SUSTAINED DRUG RELEASE; CELL LINE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECT; EMULSION; METHODOLOGY;

CELL LINE; CELL PROLIFERATION; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; EMULSIONS; HUMANS; LACTIC ACID; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; RECOMBINANT PROTEINS; SOLVENTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650491501     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2010.523795     Document Type: Article

References (42)

1. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, bio-compatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials, 1996;17:93-102.
2. Chung HJ, Park TG. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev, 2007;59:249-62.
3. Cleland JL. 1997. Protein delivery from biodegradable micro-spheres. In: Sanders L, Hendren W, eds. Protein delivery: Physical systems. New York, USA: Plenum Press, pp. 1-43.
4. Crotts G, Park TG. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues. J Microencapsul, 1998;15:699-713.
5. Dai C, Wang B, Zhao H. Microencapsulation peptide and protein drugs delivery system. Colloid Surface B: Biointerfaces, 2005;41:117-20.
6. Deng XM, Li XH, Yuan ML, Xiong CD, Huang ZT, Jia WX, Zhang YH. Optimization of preparative conditions for poly-DL-lactide-polyethylene glycol microspheres with entrapped vibrio cholera antigens. J Control Release, 1999;58:123-31.
7. Elcin YM, Dixit V, Gitnick G. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: Implications for tissue engineering and wound healing. Artif Organs, 2001;25:558-65.
8. Folkman J. Angiogenesis. Annu Rev Med, 2006;57:1-18.
9. Foqueri LR, Singh S. Smart polymers for controlled delivery of proteins and peptides: A review of patents. Recent Patents Drug Delivery Formulation, 2009;3:40-8.
10. Frokjaer S, Hovgaard L, van de Weert M., 2005. Formulation, stability, and characterization of protein and peptide drugs. In: Mahato RI, ed. Biomaterials for delivery and targeting of proteins and nucleic acids. Boca Raton: CRC Press, pp. 377-400.
11. Fu K, Klibanov AM, Langer R. Protein stability in controlled-release systems. Nat Biotechnol, 2000;18:24-5.
12. Guo Y, Baysal K, Kang B, Yang LJ, Williamson JR. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-a in rat mesangial cells. J Biol Chem, 1998;273:4027-34.
13. Heller J. Development of poly(ortho esters): A historical overview. Biomaterials, 1990;11:659-65.
14. Holmes K, Roberts OL, Thomas AM, Ross MJ. Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition. Cell Signal, 2007;19:2003-12.
15. Jaffe EA, Nachmann RL, Becker CG, Minick CR. Culture of human endothelial cells from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest, 1973;52:2745-56.
16. Jeyanthi R, Thanoo BC, Metha RC, De Luca PP. Effect of solvent removal technique on the matrix characteristics of polylactide/ glycolide microspheres for peptide delivery. J Control Release, 1996;38:235-44.
17. Jiang W, Schwendeman SP. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends. Pharm Res, 2001;18:878-85.
18. Kang J, Schwendeman SP. Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D, L-lactide-co-glycolide) implants. Biomaterials, 2002;23:239-45.
19. King TW, Patrick CW. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-gycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/ single emulsion/solvent extraction technique. J Biomed Mater Res, 2000;51:383-90.
20. Lee J, Lee KY. Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system. Pharm Res, 2009;26:1739-44.
21. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization. Proc Natl Acad Sci USA, 1979;76:5674-8.
22. Meinel L, Illi OE, Zapf J, Malfanti M, Merkle HP, Gander B. Stabilizing insulin-like growth factor-I in poly(D, L-lactide-co-glycolide) microspheres. J Control Release, 2001;70:193-202.
23. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly (D, L-lactide-co-glycolide) and its derivatives. J Control Release, 2008;125:193-209.
24. O'Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev, 1997;28:25-42.
25. Papkov MS, Agashi K, Olaye A, Shakesheff K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Del Rev, 2007;59:187-206.
26. Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials, 1995;16:1123-30.
27. Park TG, Lee HY, Nam YS. A new preparation method for protein loaded poly(D, L-lactic-co-glycolic acid) microspheres and protein release mechanism study. J Control Release, 1998;55:181-91.
28. Patil SD, Papadmitrakopoulos F, Burgess DJ. Cocurrent delivery of dexa-methasone and VEGF for localized inflammation control and angiogen-esis. J Control Release, 2007;117:68-79.
29. Paynam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly(D, L-lactide-co-glycolide) nano- and micropar-ticles. J Control Release, 2003;92:173-87.
30. Putney SD. Encapsulation of proteins for improved delivery. Curr Opin Chem Biol, 1998;2:548-52.
31. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol, 2001;19:1029-34.
32. Singh M, Shirley B, Bajwa K, Samara E, Hora M, O'Hagan D. Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles. J Control Release, 2001;70:21-8.
33. Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release, 2003;90:261-80.
34. Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev, 2007;59:187-206.
35. Tan H, Wu J, Lao L, Gao C. Gelatin/chitosan/hyaluronan scaffold integrated with PLGA microspheres for cartilage tissue engineering. Acta Biomaterialia, 2009;5:328-37.
36. van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res, 2000;17:1159-67.
37. Yang YY, Chia HH, Chung TS. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. J Control Release, 2000;69:81-96.
38. Yang YY, Chung TS, Ping NN. Morphology, drug distribution and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double emulsion solvent extraction/evaporation method. Biomaterials, 2001;22:231-41.
39. Zhang L, Schwendeman SP. 2009. Controlled release of angiogenic growth factors from poly(lactic-co-glycolic acid) implants for therapeutics angiogenesis, PhD Thesis, University of Michigan, 92-3, AAT3354244.
40. Zhu G, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nat Biotechnol, 2000;18: 52-7.
41. Zhu G, Schwendeman SP. Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: Mechanism of stabilization by basic additives. Pharm Res, 2000;17:351-7.
42. Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release, 2007;122:338-44.